Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab
-
Published:2022-05-03
Issue:1
Volume:74
Page:
-
ISSN:2240-2683
-
Container-title:Reumatismo
-
language:
-
Short-container-title:Reumatismo
Publisher
PAGEPress Publications
Reference6 articles.
1. Maranini B, Ciancio G, Cultrera R, Govoni M. Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis. Reumatismo. 2021; 73: 1445.
2. Algaadi SA. Herpes zoster and COVID-19 infection: a coincidence or a causal relationship? Infection. 2021 Nov 22: 1-5.
3. Ting SW, Ting SY, Lin YS, et al. Risk of herpes zoster in psoriasis patients receiving systemic therapies: a nationwide population-based cohort study. Sci Rep. 2021; 11: 11824.
4. Chiu YM, Tang CH, Hung ST, et al. A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study. Scand J Rheumatol. 2017; 46: 236-40.
5. Ma C, Walters B, Fedorak RN. Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn’s disease. World J Gastroenterol. 2013; 19: 3347-51.